iuvo Expands Sales Network with Established Partner Cansativa

4. November 2021

Düsseldorf / Frankfurt am Main, November 4, 2021 – iuvo Therapeutics GmbH (iuvo Therapeutics or iuvo) is expanding its sales network: Cansativa GmbH (Cansativa) now offers iuvo’s high-quality full-spectrum cannabis extracts.

iuvo Therapeutics and Cansativa have entered into a strategic distribution partnership. The well-established wholesaler with a focus on cannabis-based pharmaceuticals has expanded its product portfolio to include iuvo’s pharmaceuticals Cannabisextrakt iuvo THC26 and Cannabisextrakt iuvo Balance THC10:CBD15. While benefiting from Cansativa’s well established fulfillment & logistics services, iuvo will thus be able to further strengthen its sales reach in Germany.

“We are delighted to cooperate with such a well-established partner, highly respected by domestic pharmacists and practitioners. iuvo’s pharmaceuticals being represented in Cansativa’s portfolio will further facilitate patient access to our products in Germany,” says Daniel Seidl, Managing Director at iuvo.

“iuvo’s products are a valuable addition to the Cansativa product portfolio. We are looking forward to a successful start in sales!” says Thiago Cäsar, Head of Business Development at Cansativa.

iuvo Therapeutics’ products have been available on the German market since June 2021. The company primarily focusses on full-spectrum cannabis extracts.

About iuvo Therapeutics

The pharmaceutical company iuvo Therapeutics, founded in 2017 and headquartered in Düsseldorf, pursues the goal of reliably supplying patients in Europe with cannabis-based pharmaceuticals of the highest quality. To achieve this goal, iuvo, as an independent importer, manufacturer and wholesaler, constantly expands its manufacturer partnerships and supply chains, which have been successfully GDP and GMP certified for years. Pharmacies and a selection of pharmaceutical wholesalers are part of iuvo‘s distribution network.
The company develops its pharmaceuticals based on the state of science and in cooperation with experts in cannabis therapy, supports doctors and pharmaceutical specialists through recognized, scientific training courses. iuvo Therapeutics is an active member of the Federal Association of Pharmaceutical Cannabinoid Companies.

About Cansativa

Cansativa is the first mover in the growing medical cannabis industry. Founded in 2017, the GMP and GDP-certified company based in Frankfurt am Main and Moerfelden-Walldorf is a “one-stop shop”, covering all stages of the value chain: from import to storage and distribution to pharmacies, including transport management with an in-house distribution and fulfilment center. Being awarded the official partner of the Federal Institute for Drugs and Medical Devices (BfArM) in August 2020, Cansativa is the only company that is permitted to distribute medical cannabis cultivated in Germany.

Download press release (PDF)